Anti-CD38 antibodies for treatment of acute myeloid leukemia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10793630
APP PUB NO 20160222106A1
SERIAL NO

14956890

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods of treatment of acute myeloid leukemia with anti-CD38 antibodies.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN BIOTECH INC800 RIDGEVIEW ROAD HORSHAM PA 19044

International Classification(s)

loading....
  • 2015 Application Filing Year
  • A61K Class
  • 16157 Applications Filed
  • 11882 Patents Issued To-Date
  • 73.55 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances201520162017201820192020202120222023202420250255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Danet-Desnoyers, Gwenn Philadelphia, US 2 32
Dos, Santos Cedric San Bruno, US 2 32
Doshi, Parul Chester Springs, US 14 245
Sasser, Amy Doylestown, US 12 160
Shan, Xiaochuan Philadelphia, US 4 36

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 8 Citation Count
  • A61K Class
  • 66.68 % this patent is cited more than
  • 5 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges13636645326377163101 - 1011 - 2021 - 3031 - 4041 - 5051 - 600100020003000400050006000700080009000100001100012000130001400015000

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 6, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 6, 2032